Carriers of PALB2 mutations have a four times higher risk of breast cancer than those without (8), and those with PALB2 mutations have a 14 and 35% risk of developing breast cancer at ages 50 and 70 years, respectively (9). This evidence concerns the gene PALB2 and breast carcinoma.